Faes Farma, S.A.

BME:FAE 주식 보고서

시가총액: €1.1b

Faes Farma 미래 성장

Future 기준 확인 0/6

Faes Farma 의 수익은 연간 1.4% 감소할 것으로 예상되는 반면, 연간 수익은 1.5% 로 증가할 것으로 예상됩니다. 1.5% 연간. EPS는 연간 1.5% 만큼 쇠퇴할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.2% 로 예상됩니다.

주요 정보

-1.4%

수익 성장률

-1.5%

EPS 성장률

Pharmaceuticals 수익 성장25.9%
매출 성장률1.5%
향후 자기자본 수익률11.2%
애널리스트 커버리지

Low

마지막 업데이트21 Nov 2024

최근 미래 성장 업데이트

Recent updates

Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 03
Faes Farma, S.A. (BME:FAE) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think

Mar 01
Faes Farma, S.A. (BME:FAE) Just Released Its Full-Year Earnings: Here's What Analysts Think

Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316

Dec 18
Faes Farma (BME:FAE) Is Due To Pay A Dividend Of €0.0316

Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316

Dec 04
Faes Farma (BME:FAE) Will Pay A Dividend Of €0.0316

Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?

Nov 24
Does Faes Farma (BME:FAE) Have A Healthy Balance Sheet?

Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly

May 03
Here's Why Faes Farma (BME:FAE) Can Manage Its Debt Responsibly

Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?

Sep 21
Is There An Opportunity With Faes Farma, S.A.'s (BME:FAE) 50% Undervaluation?

Is Faes Farma (BME:FAE) A Risky Investment?

Aug 03
Is Faes Farma (BME:FAE) A Risky Investment?

Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth

Jun 17
Faes Farma (BME:FAE) Ticks All The Boxes When It Comes To Earnings Growth

Is Faes Farma (BME:FAE) Using Too Much Debt?

Mar 27
Is Faes Farma (BME:FAE) Using Too Much Debt?

Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14

Dec 13
Faes Farma (BME:FAE) Is Increasing Its Dividend To €0.14

Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17

Nov 29
Faes Farma's (BME:FAE) Dividend Will Be Increased To €0.17

Is Faes Farma (BME:FAE) A Risky Investment?

Sep 21
Is Faes Farma (BME:FAE) A Risky Investment?

Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year

Jul 31
Faes Farma, S.A. (BME:FAE) Interim Results: Here's What Analysts Are Forecasting For This Year

Is Faes Farma (BME:FAE) Using Too Much Debt?

May 01
Is Faes Farma (BME:FAE) Using Too Much Debt?

Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)

Apr 07
Estimating The Fair Value Of Faes Farma, S.A. (BME:FAE)

Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?

Mar 22
Does Faes Farma, S.A. (BME:FAE) Have A Place In Your Dividend Portfolio?

Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations

Mar 06
Faes Farma's (BME:FAE) Solid Earnings May Rest On Weak Foundations

Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment

Feb 22
Faes Farma (BME:FAE) Has Compensated Shareholders With A Respectable 61% Return On Their Investment

I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease

Jan 16
I Ran A Stock Scan For Earnings Growth And Faes Farma (BME:FAE) Passed With Ease

Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly

Dec 08
Faes Farma (BME:FAE) Seems To Use Debt Rather Sparingly

수익 및 매출 성장 예측

BME:FAE - 애널리스트의 미래 추정치 및 과거 재무 데이터 (EUR Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20265099293N/A3
12/31/20254999482N/A3
12/31/20244849061N/A3
9/30/202450498N/AN/AN/A
6/30/20244949744106N/A
3/31/202448295N/AN/AN/A
12/31/202347392-1101N/A
9/30/202347290N/AN/AN/A
6/30/202346990-998N/A
3/31/202346791N/AN/AN/A
12/31/20224628926107N/A
9/30/202246086N/AN/AN/A
6/30/20224668850113N/A
3/31/202244988N/AN/AN/A
12/31/2021429822080N/A
9/30/202141681N/AN/AN/A
6/30/202139874856N/A
3/31/202139473N/AN/AN/A
12/31/2020411735378N/A
9/30/202040877N/AN/AN/A
6/30/2020407735778N/A
3/31/202040968N/AN/AN/A
12/31/2019383644668N/A
9/30/201937960N/AN/AN/A
6/30/2019363595174N/A
3/31/201935154N/AN/AN/A
12/31/2018340524059N/A
9/30/201833451N/AN/AN/A
6/30/201833049N/A58N/A
3/31/201830847N/AN/AN/A
12/31/201728241N/A42N/A
9/30/201726639N/AN/AN/A
6/30/201725039N/A43N/A
3/31/201724138N/AN/AN/A
12/31/201623737N/A50N/A
9/30/201622635N/AN/AN/A
6/30/201622234N/A40N/A
3/31/201622032N/AN/AN/A
12/31/201521430N/A41N/A
9/30/201520728N/AN/AN/A
6/30/201520327N/A42N/A
3/31/201519626N/AN/AN/A
12/31/201419825N/A32N/A
9/30/201419523N/AN/AN/A
6/30/201419424N/A20N/A
3/31/201419220N/AN/AN/A
12/31/201319323N/A32N/A

애널리스트 미래 성장 예측

수입 대 저축률: FAE 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -1.4% ).

수익 vs 시장: FAE 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -1.4% ).

고성장 수익: FAE 의 수익은 향후 3년간 감소할 것으로 예상됩니다.

수익 대 시장: FAE 의 수익(연간 1.5% ) Spanish 시장( 4.9% 보다 느리게 성장할 것으로 예상됩니다. 4.9% 연간).

고성장 수익: FAE 의 수익(연간 1.5% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: FAE 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 11.2 %).


성장 기업 발견